ZARJENT owner Contact Information online
from Glaxo Group Limited
ZARJENT
US serial number:85182488
Application filling date:Nov. 22, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned after publication because applicant filed an express abandonment. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Oct. 24, 2011
Publication date:Apr. 12, 2011
Abandoned date:Oct. 10, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive
Current owner owner name:Glaxo Group Limited
Current owner owner address:Glaxo Wellcome House
Berkeley Avenue
Greenford, Middlesex
UNITED KINGDOM
UB60NN
Current owner legal entity type:CORPORATION
Current owner state or country:UNITED KINGDOM
Attorney name:Maribeth Day Case
Attorney email:trademarks@gsk.com
Attorney docket number:TMR/5073699/
Attorney email authorized:Yes
Correspondent name address:MARIBETH DAY CASE
GLAXOSMITHKLINE
5 MOORE DR
RESEARCH TRIANGLE PARK,
NORTH CAROLINA
UNITED STATES
27709-0143
Correspondent phone:919-483-1803
Correspondent email:trademarks@gsk.com
Correspondent fax:704-625-9190
Correspondent email authorized:Yes
Domestic representative name:Maribeth Day Case
Domestic representative phone:919-483-1803
Domestic representative fax:704-625-9190
Domestic representative email:trademarks@gsk.com
Domestic representative email authorized:Yes
Trademark staff tm attorney:YARD, JOHN S
Trademark staff law office assigned ZARJENT:LAW OFFICE 115
Latest trademarks
Popular owners
Glaxo Group Limited (178) Novartis AG (131) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) SANOFI (46) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) Wyeth LLC (41) Pfizer Inc. (39) Bristol-Myers Squibb Company (37) Forest Laboratories, Inc. (34) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Ares Trading S.A. (17) Scott Riddell (17)Popular publication dates
Apr. 12, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Apr. 19, 2011 Mar. 29, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
